Chapter
A New mRNA Vaccination Method
22:04 - 25:52 (03:47)
The mRNA vaccination method provides a more consistent way of making protein and helps the body develop a stronger immune response without overwhelming the immune cells. In contrast, traditional vaccination methods involve a three-phase trial by giving the vaccine to people and waiting to see how many get infected.
Clips
This episode explains how mRNA works within our body to create proteins and how scientists are utilizing this process to create vaccines at a faster rate in combating COVID-19.
22:04 - 23:24 (01:19)
Summary
This episode explains how mRNA works within our body to create proteins and how scientists are utilizing this process to create vaccines at a faster rate in combating COVID-19.
ChapterA New mRNA Vaccination Method
EpisodeE13: SPACsgiving Special! More promising vaccine news, innovation vs. regulation, reforming higher ed, morality of challenge trials & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
RNA has been studied as a potential treatment for diseases by making consistent protein that produces a robust immune response without overloading the immune system, using chunks of DNA coded RNA.
23:24 - 24:33 (01:08)
Summary
RNA has been studied as a potential treatment for diseases by making consistent protein that produces a robust immune response without overloading the immune system, using chunks of DNA coded RNA. Despite concerns for unknown side effects of introducing RNA in the body, RNA has made significant progress as a treatment.
ChapterA New mRNA Vaccination Method
EpisodeE13: SPACsgiving Special! More promising vaccine news, innovation vs. regulation, reforming higher ed, morality of challenge trials & more
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
The development of vaccines may become faster with the use of genome sequencing, and human trials can be hastened with the use of challenge trials to test its effectiveness.
24:33 - 25:52 (01:18)
Summary
The development of vaccines may become faster with the use of genome sequencing, and human trials can be hastened with the use of challenge trials to test its effectiveness.